The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6
Open accessAbstract
We present a simple and safe strategy for producing high-titer adeno-associated virus (AAV) vectors derived from six different AAV serotypes (AAV-1 to AAV-6). The method, referred to as "HOT," is helper virus free, optically controllable, and based on transfection of only two plasmids, i.e., an AAV vector construct and one of six novel AAV helper plasmids. The latter were engineered to carry AAV serotype rep and cap genes together with adenoviral helper functions, as well as unique fluorescent protein expression cassettes, allowing confirmation of successful transfection and identification of the transfected plasmid. Cross-packaging of vector DNA derived from AAV-2, -3, or -6 was up to 10-fold more efficient using our novel plasmids, compared to a conservative adenovirus-dependent method. We also identified a variety of useful antibodies, allowing detection of Rep or VP proteins, or assembled capsids, of all six AAV serotypes. Finally, we describe unique cell tropisms and kinetics of transgene expression for AAV serotype vectors in primary or transformed cells from four different species. In sum, the HOT strategy and the antibodies presented here, together with the reported findings, should facilitate and support the further development of AAV serotype vectors as powerful new tools for human gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the majority of rAAV vectors, the ITRs and rep gene of serotype 2 (AAV2) are utilized resulting in pseudo-typed rAAVs [11].”
From Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses (2017) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409
Zolotukhin, S., Byrne, B. J., Mason, E. G., Zolotukhin, I., Potter, M., Chesnut, K. A., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,321
Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B. E., Chew, A. K., Tai, S. J., Herzog, R. W., et al. (2000) · Nature Genetics · doi:10.1038/73464 · Cited by 1,019
Self-citationRabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 701
Self-citationA "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4646-4654.1996 · Cited by 609
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
Current protocols in human genetics
Bates, G. P. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89147-7 · Cited by 484
Cited by
Sorted by citations
Items 201–300 of 344
Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Kremer, E. J. (2005) · Current Genomics · doi:10.2174/1389202053202111 · Cited by 21
The use of recombinant adeno‐associated virus for skeletal gene therapy
Dai, J., & Rabie, A. B. M. (2007) · Orthodontics and Craniofacial Research · doi:10.1111/j.1601-6343.2007.00381.x · Cited by 22
Callander, G. E., Ma, S., Ganella, D. E., Wimmer, V. C., Gundlach, A. L., Thomas, W. G., & Bathgate, R. A. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042300 · Cited by 20
Yang, J., Pattanayak, A., Song, M., Kou, J., Taguchi, H., Paul, S., Ponnazhagan, S., Lalonde, R., & Fukuchi, K.-I. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9877-3 · Cited by 20
Moreau, A., Vicente, R., Dubreil, L., Adjali, O., Podevin, G., Jacquet, C., Deschamps, J. Y., Klatzmann, D., Chérel, Y., Taylor, N. N., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.272 · Cited by 22
Feiner, R. C., Teschner, J., Teschner, K. E., Radukic, M. T., Baumann, T., Hagen, S. H., Hannappel, Y., Biere, N., Anselmetti, D., Arndt, K. M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225702 · Cited by 19
A Chemogenetic Tool that Enables Functional Neural Circuit Analysis
Ngo, H. B., Melo, M., Layfield, S. L., Connelly, A. A., Bassi, J. K., Xie, L., Menuet, C., McDougall, S. J., Bathgate, R. A. D., & Allen, A. M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108139 · Cited by 19
Nieto, K., Kern, A., Leuchs, B., Gissmann, L., Müller, M., & Kleinschmidt, J. A. (2009) · Antiviral Therapy · doi:10.3851/imp1469 · Cited by 21
Self-citationAAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice
Heckmann, M. B., Bauer, R., Jungmann, A., Winter, L., Rapti, K., Strucksberg, K.-H., Clemen, C. S., Li, Z., Schröder, R., Katus, H. A., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.40 · Cited by 19
Short regulatory DNA sequences to target brain endothelial cells for gene therapy
Graßhoff, H., Müller‐Fielitz, H., Dogbevia, G. K., Körbelin, J., Bannach, J., Vahldieck, C., Kusche-Vihrog, K., Jöhren, O., Müller, O. J., Nogueiras, R., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211039617 · Cited by 17
AAV vector-mediated secretion of chondroitinase provides a sensitive tracer for axonal arborisations
Alves, J. N., Muir, E. M., Andrews, M. R., Ward, A., Michelmore, N., Dasgupta, D., Verhaagen, J., Moloney, E. B., Keynes, R. J., Fawcett, J. W., et al. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.02.010 · Cited by 18
Gene Therapy in Corneal Transplantation
Qazi, Y., & Hamrah, P. (2013) · Seminars in Ophthalmology · doi:10.3109/08820538.2013.825297 · Cited by 18
Vaessen, S. F. C., Veldman, R. J., Comijn, E. M., Snapper, J., Sierts, J. A., van den Oever, K., Beattie, S. G., Twisk, J., & Kuivenhoven, J. A. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1344 · Cited by 18
Methods in Molecular Biology TM
Martin, S. G., Murray, C., Hewitson, T. D., Becker, G. J., Brown, C., & Vančura, A. (2008) · Cited by 18
Wang, J. P., Hasan, M. T., & Seung, H. S. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.06.024 · Cited by 18
Grund, A., Szaroszyk, M., Döppner, J. K., Mohammadi, M. M., Kattih, B., Korf‐Klingebiel, M., Gigina, A., Scherr, M., Kensah, G., Jara-Avaca, M., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy154 · Cited by 17
Pouzolles, M., Machado, A., Guilbaud, M., Irla, M., Gailhac, S., Barennes, P., Cesana, D., Calabria, A., Benedicenti, F., Sergé, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.029 · Cited by 17
Horstmann, H., Vasileva, M., & Kuner, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064764 · Cited by 17
AAV-mediated cardiac gene transfer of wild-type desmin in mouse models for recessive desminopathies
Ruppert, T., Heckmann, M. B., Rapti, K., Schultheis, D., Jungmann, A., Katus, H. A., Winter, L., Frey, N., Clemen, C. S., Schröder, R., et al. (2020) · Gene Therapy · doi:10.1038/s41434-020-0147-7 · Cited by 16
Rodnyy, A., Kondaurova, E., Bazovkina, D., Kulikova, E., Ilchibaeva, T., Kovetskaya, A. I., Baraboshkina, I., Bazhenova, E., Popova, N., & Naumenko, V. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25055 · Cited by 16
Arnett, A. L. H., Garikipati, D. K., Wang, Z., Tapscott, S. J., & Chamberlain, J. S. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00220 · Cited by 16
RE-DESIGN OF DOWNSTREAM PROCESSING TECHNIQUES FOR NANOPARTICULATE BIOPRODUCTS
Jahanshahi, M. (2004) · Iranian Journal of Biotechnology · Cited by 16
Pearce, H. A., Qian, H., Connell, T. U., Huang, D., Gottstein, C., Donnelly, P. S., Peter, K., Gregorevic, P., & Hagemeyer, C. E. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.07.003 · Cited by 16
Lentiviral and Adeno-Associated Vector-Based Therapy for Motor Neuron Disease Through RNAi
Towne, C. L., & Aebischer, P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-295-7_7 · Cited by 16
Versatility of gene therapy vectors through viruses
Barzon, L., Stefani, A., Pacenti, M., & Palù, G. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.639 · Cited by 16
Li, Z., Wang, X., Janssen, J. M., Liu, J., Tasca, F., Hoeben, R. C., & Gonçalves, M. A. F. V. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1213 · Cited by 14
Wang, S., & Xiao, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052213 · Cited by 18
Effects of a Cc2d1a/Freud-1 Knockdown in the Hippocampus on Behavior, the Serotonin System, and BDNF
Kondaurova, E. M., Plyusnina, A. V., Ilchibaeva, T. V., Eremin, D. V., Rodnyy, A. Y., Grygoreva, Y. D., & Naumenko, V. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413319 · Cited by 15
Gene therapy in cutaneous wound healing
Hirsch, T. (2006) · Frontiers in bioscience · doi:10.2741/2251 · Cited by 15
Seol, M., & Kuner, T. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13084 · Cited by 15
Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors
Mohiuddin, I. T., Loiler, S., Zolotukhin, I., Byrne, B. J., Flotte, T. R., & Snyder, R. O. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.030 · Cited by 15
Distributed feature representations of natural stimuli across parallel retinal pathways
Hsiang, J.-C., Shen, N., Soto, F., & Kerschensteiner, D. (2024) · Nature Communications · doi:10.1038/s41467-024-46348-y · Cited by 16
de Backer, M. W. A., Brans, M. A. D., van Rozen, A. J., van der Zwaal, E. M., Luijendijk, M. C. M., Garner, K. M., de Krom, M., van Beekum, O., la Fleur, S. E., & Adan, R. A. H. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0057 · Cited by 14
Bockstael, O., Melas, C., Pythoud, C., Levivier, M., McCarty, D. M., Samulski, R. J., Witte, O. D., & Tenenbaum, L. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.216 · Cited by 15
Recombinant adeno-associated virus vector hybrids efficiently target different skeletal cells
Dai, J. (2007) · Frontiers in bioscience · doi:10.2741/2387 · Cited by 14
Vasileva, M., Renden, R., Horstmann, H., Gitler, D., & Kuner, T. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00270 · Cited by 10
Lang, S. I., Boelz, S., Stroh-Dege, A., Rommelaere, J., Dinsart, C., & Cornelis, J. J. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.289-298.2005 · Cited by 13
Granier, C., Schwarting, J., Fourli, E., Gaupp, F. M. L., Hennrich, A. A., Schmalz, A., Jacobi, A., Wesolowski, M., Conzelmann, K., & Bareyre, F. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-67866-x · Cited by 13
Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
Gould, N. L., Sharma, V. K., Hleihil, M., Chandran, S. K., David, O., Edry, E., & Rosenblum, K. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1243-20.2020 · Cited by 14
Direct AAV-mediated gene delivery to the temporomandibular joint
Dai, J. (2006) · Frontiers in bioscience · doi:10.2741/2224 · Cited by 13
Dassie, E., Andrews, M. R., Bensadoun, J., Cacquevel, M., Schneider, B. L., Aebischer, P., Wouters, F. S., Richardson, J. C., Hussain, I., Howlett, D. R., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.011 · Cited by 12
Genome length determination in adeno-associated virus vectors with mass photometry
Hiemenz, C., Baumeister, N., Helbig, C., Hawe, A., Babutzka, S., Michalakis, S., Frieß, W., & Menzen, T. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101162 · Cited by 11
Preclinical Studies for Gene Therapy of Duchenne Muscular Dystrophy
Odom, G. L., Banks, G. B., Schultz, B. R., Gregorevic, P., & Chamberlain, J. S. (2010) · Journal of Child Neurology · doi:10.1177/0883073810371006 · Cited by 12
de Backer, M. W. A., Fitzsimons, C. P., Brans, M. A. D., Luijendijk, M. C. M., Garner, K. M., Vreugdenhil, E., & Adan, R. A. H. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-81 · Cited by 15
Pelzer, P., Horstmann, H., & Kuner, T. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00003 · Cited by 12
Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice
Verma, A., Ray, A., Bapat, D., Diwakar, L., Kommaddi, R. P., Schneider, B. L., Hirsch, E. C., & Ravindranath, V. (2020) · Movement Disorders · doi:10.1002/mds.28190 · Cited by 12
Fakhiri, J., Linse, K.-P., Mietzsch, M., Xu, M., Schneider, M. A., Meister, M. A., Schildgen, O., Schnitzler, P., Söderlund‐Venermo, M., Agbandje‐McKenna, M., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00170-20 · Cited by 12
Self-citationvan Lieshout, L. P., Ota, S., Adusei, A., Wiberg, E., Costa-Grant, K., Lata, D., Dollive, S., Stanvick, M., Iwuchukwu, I., Golebiowski, D., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.059 · Cited by 11
Somatostatin Interneurons of the Insula Mediate QR2-Dependent Novel Taste Memory Enhancement
Gould, N. L., Chandran, S. K., Kayyal, H., Edry, E., & Rosenblum, K. (2021) · eNeuro · doi:10.1523/eneuro.0152-21.2021 · Cited by 13
Comparison of AAV Serotypes for Gene Delivery to Dopaminergic Neurons in the Substantia Nigra
Korecka, J. A., Schouten, M., Eggers, R., Ulusoy, A., Bossers, K., & Verhaage, J. (2011) · InTech eBooks · doi:10.5772/18939 · Cited by 11
rAAV Vector Product Characterization and Stability Studies
Snyder, R. O., Audit, M., & Francis, J. D. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_17 · Cited by 11
Kakava-Georgiadou, N., Zwartkruis, M. M., Bullich‐Vilarrubias, C., Luijendijk, M. C. M., Garner, K. M., van der Plasse, G., & Adan, R. A. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00049 · Cited by 10
Fluri, D. A., Baba, M. D., & Fussenegger, M. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-75 · Cited by 11
Alsalloum, M., Ilchibaeva, T. V., Tsybko, A. S., Eremin, D. V., & Naumenko, V. S. (2023) · Biomedicines · doi:10.3390/biomedicines11092573 · Cited by 10
Steininger, T., Öttl, V., Franken, L. E., Frank, C., Ohland, P., Ferreiro, M., Klostermann, S., Fritsch, J., Hirschauer, E., Sandmeir, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031319 · Cited by 10
Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction
Sasipong, N., Schlegel, P., Wingert, J., Lederer, C., Meinhardt, E., Ziefer, A., Schmidt, C., Rapti, K., Thoeni, C. E., Frey, N., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.010 · Cited by 10
Inhibition and regression of atherosclerotic lesions.
Oka, K., & Chan, L. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3444 · Cited by 10
Recombinant Adeno-Associated Viral Vectors
de Backer, M. W. A., Garner, K. M., Luijendijk, M. C. M., & Adan, R. A. H. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-310-3_24 · Cited by 9
Recombinant Adeno-Associated Viral Vector Reference Standards
Moullier, P., & Snyder, R. O. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-386509-0.00015-6 · Cited by 10
Pinkenburg, O., Pfosser, A., Hinkel, R., Böttcher, M., Dinges, C., Lebherz, C., Sultana, S., Enssle, J., El-Aouni, C., Büning, H., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2007.178 · Cited by 9
Dreesen, I. A. J., Luechinger, N. A., Stark, W. J., & Fussenegger, M. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22157 · Cited by 8
Augmented transgene expression in transformed cells using a parvoviral hybrid vector
Krüger, L., Eskerski, H., Dinsart, C., Cornelis, J. J., Rommelaere, J., Haberkorn, U., & Kleinschmidt, J. A. (2008) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701113 · Cited by 8
Self-citationThe amazing AAV capsids: Into the structure-verse
Hsi, J., Mietzsch, M., & McKENNA, R. V. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101629 · Cited by 9
Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
Bieber, S. D., Halldorson, J. B., Finn, E. E., Ahmad, S., Chamberlain, J. S., & Odom, G. L. (2013) · Scientific Reports · doi:10.1038/srep01538 · Cited by 6
Approaches to purification and concentration of rAAV vectors for gene therapy
Belova, L., Kochergin-Nikitsky, K. S., Erofeeva, A., Лавров, А. В., & Smirnikhina, S. (2022) · BioEssays · doi:10.1002/bies.202200019 · Cited by 8
Gene therapy with anabolic growth factors to prevent muscle atrophy
Schakman, O., & Thissen, J. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000222101.21385.a6 · Cited by 7
Adeno-associated virus vectors for human gene therapy
Chen, H. (2015) · World Journal of Medical Genetics · doi:10.5496/wjmg.v5.i3.28 · Cited by 8
Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques
Cho, G. Y., Bolo, K. A., Park, K. S., Sengillo, J. D., & Tsang, S. H. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0377-1 · Cited by 8
Overexpression of Calretinin Enhances Short-Term Synaptic Depression
Bolshakov, A. P., Kolleker, A., Volkova, E. P., Valiullina, F., Kolosov, P. M., & Rozov, A. V. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00091 · Cited by 6
AAV library screening identifies novel vector for efficient transduction of human aorta
Schröder, L. C., Hüttermann, L., Remes, A. K., Voran, J. C., Hille, S. S., Sommer, W., Lutter, G., Warnecke, G., Frank, D., Schade, D., et al. (2024) · Gene Therapy · doi:10.1038/s41434-024-00511-8 · Cited by 6
Goody two plasmids: An optimized transient transfection system for AAV vector production
Moreno-Velásquez, S. D., Gerstmann, E., & Grimm, D. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.06.010 · Cited by 6
Self-citationBüning, H., Fehse, B., Ivics, Z., Kochanek, S., Koehl, U., Kupatt, C., Mussolino, C., Nettelbeck, D. M., Schambach, A., Uckert, W., et al. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.29178.hbu · Cited by 6
Ulusoy, A., & Kirik, D. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.95 · Cited by 6
Wykes, A. D., Ma, S., Bathgate, R. A. D., & Gundlach, A. L. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.11.006 · Cited by 6
The 5-HT4 receptor interacts with adhesion molecule L1 to modulate morphogenic signaling in neurons
Sonnenberg, S., Rauer, J., Göhr, C., Gorinski, N., Schade, S. K., Galil, D. A., Naumenko, V. S., Zeug, A., Bischoff, S. C., Ponimaskin, E. G., et al. (2021) · Journal of Cell Science · doi:10.1242/jcs.249193 · Cited by 6
Kaminskaya, Y. P., Ilchibaeva, T. V., Shcherbakova, A. I., Allayarova, E. R., Popova, N. K., Naumenko, V. S., & Tsybko, A. S. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924080091 · Cited by 5
Melo, M., Wykes, A. D., Connelly, A. A., Bassi, J. K., Cheung, S., McDougall, S. J., Menuet, C., Bathgate, R. A. D., & Allen, A. M. (2023) · eLife · doi:10.7554/elife.85398 · Cited by 5
Lee, H., KIM, J. Y., LEE, W. I., Kim, S. J., Ko, M. J., Jeong-Yu, S., Park, K., Choe, H., & Lee, H. (2011) · Oncology Letters · doi:10.3892/ol.2011.376 · Cited by 5
Kakava-Georgiadou, N., Bullich‐Vilarrubias, C., Zwartkruis, M. M., Luijendijk, M. C. M., Garner, K. M., & Adan, R. A. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-47417-9 · Cited by 5
Belokopytova, I. I., Kondaurova, E. M., Kulikova, E. A., Ilchibaeva, T. V., Naumenko, V. S., & Popova, N. K. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922100145 · Cited by 5
Optogenetic silencing of neurotransmitter release with a naturally occurring invertebrate rhodopsinPreprint
Mahn, M., Saraf‐Sinik, I., Patil, P., Pulin, M., Bitton, E., Karalis, N., Bruentgens, F., Palgi, S., Gat, A., Dine, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.18.431673 · Cited by 5
Gaudry, J.-P., Aebi, A., Valdés, P., & Schneider, B. L. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3878-1_4 · Cited by 4
Egorova, T. V., Piskunov, A. A., & Poteryaev, D. A. (2024) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2024-24-2-123-139 · Cited by 5
Genotyping of AAV Plasmid Stocks: Quality Control in Adeno-Associated Virus Vector Production
Schmitt, M., Pawlita, M., & Kleinschmidt, J. A. (2010) · Microbial Physiology · doi:10.1159/000321449 · Cited by 4
Self-citationA synthetic platform for developing recombinant adeno‐associated virus type 8 producer cell lines
Lin, Y., Kuo, H., Lu, M., Mahl, T., Aslanidi, G., & Hu, W. (2025) · Biotechnology Progress · doi:10.1002/btpr.70009 · Cited by 4
Davidsson, M., & Heuer, A. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.314309 · Cited by 4
Ganjam, G. K., Benzler, J., Pinkenburg, O., Boucsein, A., Stöhr, S., Steger, J., Culmsee, C., Barrett, P., & Tups, A. (2013) · Journal of Comparative Physiology B · doi:10.1007/s00360-013-0772-1 · Cited by 4
Using Recombinant Adeno-Associated Viral Vectors for Gene Expression in the Brain
der Perren, A. V., Toelen, J., Taymans, J., & Baekelandt, V. (2011) · Neuromethods · doi:10.1007/978-1-61779-533-6_3 · Cited by 4
InXy and SeXy, compact heterologous reporter proteins for mammalian cells
Fluri, D. A., Kelm, J. M., Lesage, G., Baba, M. D., & Fussenegger, M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21461 · Cited by 4
Printz, Y., Patil, P., Mahn, M., Benjamin, A., Litvin, A., Levy, R., Bringmann, M., & Yizhar, O. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.07.467611 · Cited by 4
Zanker, J., Hüser, D., Savy, A., Lázaro-Petri, S., Hammer, E.-M., Schwarzer, C., & Heilbronn, R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1280556 · Cited by 3
An Overview of rAAV Vector Product Development for Gene Therapy
Snyder, R. O. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-3228-3_2 · Cited by 4
Stiles, K. M., Frenk, E. Z., Kaminsky, S. M., & Crystal, R. G. (2022) · Human Gene Therapy · doi:10.1089/hum.2021.200 · Cited by 3
RANGE: Gene Transfer of Reversibly Controlled Polycistronic Genes
Chen, Y., Cao, L., Luo, C., Ditzel, D. A. W., Peter, J., & Sprengel, R. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.15 · Cited by 3
Viral Vectors for Gene Delivery
Dismuke, D. J., Gray, S. J., Hirsch, M. L., Samulski, R. J., & Muzyczka, N. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732239-00338 · Cited by 3
Functional Enhancement of Skeletal Muscle by Gene Transfer
Gregorevic, P., & Chamberlain, J. S. (2005) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2005.08.011 · Cited by 3
AAV8-based gene replacement therapy for hereditary spastic paraplegia type 5
Wiora, L., Yuan, Q., Hook, S., Kraft, M., Björkhem, I., Ott, M., Hauser, S., & Schöls, L. J. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101531 · Cited by 2
Manufacturing of Viral Gene Therapies
Ramirez, G. A., & Gasmi, M. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000362 · Cited by 2
Gene Delivery and Gene Therapy for Alzheimer’s Disease
Woodbury, M. E., Kiyota, T., & Ikezu, T. (2015) · Neuromethods · doi:10.1007/978-1-4939-2306-9_4 · Cited by 2
The role of astrocytes for oligodendrocyte death and remyelination
Wrzos, C. (2013) · doi:10.53846/goediss-3520 · Cited by 2
Metadata
- Authors
- Grimm, D., Kay, M. A., & Kleinschmidt, J. A.
- Affiliations
- Stanford Medicine (US)
- German Cancer Research Center (DE)
- Corresponding author
- Kay, Mark A
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 7
- Issue
- 6
- Pages
- 839-850
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1977797303
- Cited by
- 344
- References
- 36
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 12 · 2023: 10 · 2022: 15 · 2021: 17 · 2020: 12 · 2019: 18 · 2018: 5 · 2017: 17 · 2016: 7 · 2015: 21 · 2014: 12 · 2013: 20 · 2012: 19
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL66948, U01HL066948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- adeno-associated virus vectors, fluorescent protein markers, cell tropism, transgene expression kinetics, gene therapy vectors
- MeSH terms
- Dependovirus, Cell Line, DNA Replication, DNA-Binding Proteins, Genetic Vectors, Helper Viruses, Humans, Plasmids, Serotyping, Viral Proteins, Virus Replication, Virus Assembly
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review